ѭ֤ҽѧÊõÓïÖÐÓ¢ÎĶÔÕÕ¼°ÊÍÒå

a priori£ºÔ¤ÏÈ ABI£º¾ø¶Ô»ñÒæÔö¼Ó£¨¼ûabsolute benefit increase£©absolute benefit increase£¨ABI£©£º¾ø¶Ô»ñÒæÔö¼Ó absolute risk£¨AR£©£º¾»Î£ÏÕÐÔ£¯Ê¼þ·¢ÉúÂÊ£¯¾ø¶ÔΣÏÕ¶È absolute risk increase£¨ARI£©£º¾ø¶ÔΣÏÕÐÔÔö¸ß absolute risk reduction£¨ARR£©£º¾ø¶ÔΣÏÕÐÔ½µµÍ abstract£ºÕªÒª accreditation£ºÈÏÖ¤ accuracy£º×¼È·ÐÔ ACP Journal Club£ºÃÀ¹úÄÚ¿ÆҽʦѧԺÔÓÖ¾¾ãÀÖ²¿ active surveillance£ºÖ÷¶¯¼à²â additive model£ºÌí¼ÓÄ£ÐÍ adjusted analysis£ºÐ£Õý·ÖÎö adminors£ºµçÓÊÌÖÂÛ×é¹ÜÀíÕßÃûµ¥ admission rate bias£¨Berkson bias£©£ºÈëÔºÂÊÆ«ÒУ¨²®¿ËÉ­Æ«ÒУ©adverse drug reaction£ºÒ©Îï²»Á¼·´Ó¦ adverse effect£º¸±×÷Óà adverse event£º²»Á¼Ê¼þ adverse reaction£º²»Á¼·´Ó¦£¨¼ûadverse event£©advocacy and support groups£º¹ÄÀø¼°Ö§³Ö×éÖ¯ aggregate data£º¾Û¼¯Êý¾Ý aggregation bias£ºÈºÌåÆ«ÒУ¯¾Û¼¯Æ«ÒУ¨¼ûecological fallacv£©allocation bias£º·ÖÅäÆ«ÒÐ allocation concealment£º·ÖÅäÒþ²Ø allopathic medicine£¨AM£©£º¶Ô¿¹ÁÆ·¨ alternative hypothesis£º±¸Ôñ¼ÙÉ裨¼ûhypothesis£©¡­¡­